Literature DB >> 11935271

Co-occurrence of Parkinson's disease with progressive supranuclear palsy.

Alexander R Judkins1, Mark S Forman, Kunihiro Uryu, David A Hinkle, Arthur K Asbury, Virginia M-Y Lee, John Q Trojanowski.   

Abstract

Parkinson's disease (PD) and progressive supranuclear palsy (PSP) are distinct neurodegenerative disorders. We describe an 81-year-old woman with 3 years of progressive gait unsteadiness, frequent falls, and mild cognitive dysfunction, all considered clinically to be an early fronto-temporal neurodegenerative disorder. She died of an acute myocardial infarction. Examination of her brain revealed alpha-synuclein- and tau-positive inclusions diagnostic of PD and PSP. Immunoelectron microscopy and Western blot analysis confirmed combined PD/PSP. This case provides strategies for the reliable molecular validation of concomitant PD and PSP, and demonstrates the utility of these techniques in patients with atypical clinical presentations.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11935271     DOI: 10.1007/s00401-001-0483-7

Source DB:  PubMed          Journal:  Acta Neuropathol        ISSN: 0001-6322            Impact factor:   17.088


  12 in total

Review 1.  Co-existence of Parkinson's disease and progressive supranuclear palsy: case report and a review of the literature.

Authors:  Kumar Abhinav; Laura Marsh; Barbara Crain; Stephen G Reich; Kevin Biglan
Journal:  Neurol Sci       Date:  2010-08-25       Impact factor: 3.307

2.  α-Synuclein modifies mutant huntingtin aggregation and neurotoxicity in Drosophila.

Authors:  Gonçalo M Poças; Joana Branco-Santos; Federico Herrera; Tiago Fleming Outeiro; Pedro M Domingos
Journal:  Hum Mol Genet       Date:  2014-12-01       Impact factor: 6.150

3.  Concomitant pathologies among a spectrum of parkinsonian disorders.

Authors:  Brittany N Dugger; Charles H Adler; Holly A Shill; John Caviness; Sandra Jacobson; Erika Driver-Dunckley; Thomas G Beach
Journal:  Parkinsonism Relat Disord       Date:  2014-02-22       Impact factor: 4.891

4.  Tau and alpha-synuclein pathology in amygdala of Parkinsonism-dementia complex patients of Guam.

Authors:  Mark S Forman; M Luise Schmidt; Sanjay Kasturi; Daniel P Perl; Virginia M-Y Lee; John Q Trojanowski
Journal:  Am J Pathol       Date:  2002-05       Impact factor: 4.307

5.  The neurotoxin, MPP+, induces hyperphosphorylation of Tau, in the presence of alpha-Synuclein, in SH-SY5Y neuroblastoma cells.

Authors:  Tetyana Duka; Anita Sidhu
Journal:  Neurotox Res       Date:  2006-08       Impact factor: 3.911

6.  Concomitant accumulation of α-synuclein and TDP-43 in a patient with corticobasal degeneration.

Authors:  Satoshi Yamashita; Naomi Sakashita; Taro Yamashita; Nozomu Tawara; Masayoshi Tasaki; Kensuke Kawakami; Yoshihiro Komohara; Yukio Fujiwara; Masashi Kamikawa; Takenobu Nakagawa; Teruyuki Hirano; Yasushi Maeda; Masato Hasegawa; Motohiro Takeya; Yukio Ando
Journal:  J Neurol       Date:  2014-09-11       Impact factor: 4.849

7.  Expression of the small heat-shock protein alphaB-crystallin in tauopathies with glial pathology.

Authors:  Deepa V Dabir; John Q Trojanowski; Christiane Richter-Landsberg; Virginia M-Y Lee; Mark S Forman
Journal:  Am J Pathol       Date:  2004-01       Impact factor: 4.307

8.  Clinical Features of Patients with Concomitant Parkinson's Disease and Progressive Supranuclear Palsy Pathology.

Authors:  Heather B Rigby; Brittany N Dugger; Joseph G Hentz; Charles H Adler; Thomas G Beach; Holly A Shill; Erika Driver-Dunckley; Marwan N Sabbagh; Lucia I Sue; John N Caviness
Journal:  Mov Disord Clin Pract       Date:  2014-10-29

9.  Tau enhances α-synuclein aggregation and toxicity in cellular models of synucleinopathy.

Authors:  Nahuai Badiola; Rita Machado de Oliveira; Federico Herrera; Cristina Guardia-Laguarta; Susana A Gonçalves; Marta Pera; Marc Suárez-Calvet; Jordi Clarimon; Tiago Fleming Outeiro; Alberto Lleó
Journal:  PLoS One       Date:  2011-10-24       Impact factor: 3.240

10.  Midbrain catecholaminergic neurons co-express α-synuclein and tau in progressive supranuclear palsy.

Authors:  María Elena Erro Aguirre; María Victoria Zelaya; Javier Sánchez Ruiz de Gordoa; María Teresa Tuñón; José Luis Lanciego
Journal:  Front Neuroanat       Date:  2015-03-11       Impact factor: 3.856

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.